These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 30304975)

  • 1. Serum levels of IL-6, IL-8, and IL-10 are indicators of prognosis in pancreatic cancer.
    Feng L; Qi Q; Wang P; Chen H; Chen Z; Meng Z; Liu L
    J Int Med Res; 2018 Dec; 46(12):5228-5236. PubMed ID: 30304975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokines in pancreatic carcinoma: correlation with phenotypic characteristics and prognosis.
    Ebrahimi B; Tucker SL; Li D; Abbruzzese JL; Kurzrock R
    Cancer; 2004 Dec; 101(12):2727-36. PubMed ID: 15526319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-8, a promising predictor for prognosis of pancreatic cancer.
    Chen Y; Shi M; Yu GZ; Qin XR; Jin G; Chen P; Zhu MH
    World J Gastroenterol; 2012 Mar; 18(10):1123-9. PubMed ID: 22416189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concentration of interleukin-6 (IL-6), interleukin-8 (IL-8) and interleukin-10 (IL-10) in blood serum of breast cancer patients.
    Kozłowski L; Zakrzewska I; Tokajuk P; Wojtukiewicz MZ
    Rocz Akad Med Bialymst; 2003; 48():82-4. PubMed ID: 14737948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum interleukin-6 is associated with pancreatic ductal adenocarcinoma progression pattern.
    Kim HW; Lee JC; Paik KH; Kang J; Kim J; Hwang JH
    Medicine (Baltimore); 2017 Feb; 96(5):e5926. PubMed ID: 28151872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic role of serum interleukin-18 in gastric cancer patients.
    Thong-Ngam D; Tangkijvanich P; Lerknimitr R; Mahachai V; Theamboonlers A; Poovorawan Y
    World J Gastroenterol; 2006 Jul; 12(28):4473-7. PubMed ID: 16874857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of patients with advanced pancreatic cancer and high serum interleukin-6 levels.
    Miura T; Mitsunaga S; Ikeda M; Shimizu S; Ohno I; Takahashi H; Furuse J; Inagaki M; Higashi S; Kato H; Terao K; Ochiai A
    Pancreas; 2015 Jul; 44(5):756-63. PubMed ID: 25931255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Serum Interleukin-17 (IL-17) Levels as a Diagnostic Marker in Pancreatic Adenocarcinoma.
    Karabulut S; Afsar ÇU; Karabulut M; Alış H; Kılıc L; Çikot M; Yasasever CT; Aykan NF
    J Gastrointest Cancer; 2016 Mar; 47(1):47-54. PubMed ID: 26637231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of outcome in cancer patients with febrile neutropenia: comparison of the Multinational Association of Supportive Care in Cancer risk-index score with procalcitonin, C-reactive protein, serum amyloid A, and interleukins-1beta, -6, -8 and -10.
    Uys A; Rapoport BL; Fickl H; Meyer PW; Anderson R
    Eur J Cancer Care (Engl); 2007 Nov; 16(6):475-83. PubMed ID: 17944761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An exploratory study of inflammatory cytokines as prognostic biomarkers in patients with ductal pancreatic adenocarcinoma.
    Dima SO; Tanase C; Albulescu R; Herlea V; Chivu-Economescu M; Purnichescu-Purtan R; Dumitrascu T; Duda DG; Popescu I
    Pancreas; 2012 Oct; 41(7):1001-7. PubMed ID: 22722257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic and Prognostic Impact of Circulating YKL-40, IL-6, and CA 19.9 in Patients with Pancreatic Cancer.
    Schultz NA; Christensen IJ; Werner J; Giese N; Jensen BV; Larsen O; Bjerregaard JK; Pfeiffer P; Calatayud D; Nielsen SE; Yilmaz MK; Holländer NH; Wøjdemann M; Bojesen SE; Nielsen KR; Johansen JS
    PLoS One; 2013; 8(6):e67059. PubMed ID: 23840582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating levels of interleukin-10 and interleukin-6 in gastric and colon cancer patients before and after surgery: relationship with radicality and outcome.
    Galizia G; Lieto E; De Vita F; Romano C; Orditura M; Castellano P; Imperatore V; Infusino S; Catalano G; Pignatelli C
    J Interferon Cytokine Res; 2002 Apr; 22(4):473-82. PubMed ID: 12034030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing immunological surgical stress markers in patients undergoing digestive surgery for pancreatic, hepatic and gastric tumors.
    Munteanu A; Munteanu D; Iancu M; Lupan I; Samasca G; Aldea C; Mocan T; Iancu C
    J BUON; 2018; 23(6):1655. PubMed ID: 30610790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum levels of interleukin-6 and interleukin-10 in Turkish patients with aggressive non-Hodgkin's lymphoma.
    Guney N; Soydinc HO; Basaran M; Bavbek S; Derin D; Camlica H; Yasasever V; Topuz E
    Asian Pac J Cancer Prev; 2009; 10(4):669-74. PubMed ID: 19827892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A combined prognostic serum interleukin-8 and interleukin-6 classifier for stage 1 lung cancer in the prostate, lung, colorectal, and ovarian cancer screening trial.
    Ryan BM; Pine SR; Chaturvedi AK; Caporaso N; Harris CC
    J Thorac Oncol; 2014 Oct; 9(10):1494-503. PubMed ID: 25170636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of IL-2, IL-6, IL-8 and IL-10 in Malignant Melanoma Diagnostics.
    Kucera R; Topolcan O; Treskova I; Kinkorova J; Windrichova J; Fuchsova R; Svobodova S; Treska V; Babuska V; Novak J; Smejkal J
    Anticancer Res; 2015 Jun; 35(6):3537-41. PubMed ID: 26026122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between S100A4 protein expression and pre-operative serum CA19.9 levels in pancreatic carcinoma and its prognostic significance.
    Jia F; Liu M; Li X; Zhang F; Yue S; Liu J
    World J Surg Oncol; 2019 Sep; 17(1):163. PubMed ID: 31526392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survivin expression and serum levels in pancreatic cancer.
    Dong H; Qian D; Wang Y; Meng L; Chen D; Ji X; Feng W
    World J Surg Oncol; 2015 May; 13():189. PubMed ID: 26016480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-6, IL-8 and TNF-α levels correlate with disease stage in breast cancer patients.
    Ma Y; Ren Y; Dai ZJ; Wu CJ; Ji YH; Xu J
    Adv Clin Exp Med; 2017; 26(3):421-426. PubMed ID: 28791816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Th1 and Th2 profiles in patients with pancreatic cancer compared with chronic pancreatitis.
    Seicean A; Popa D; Mocan T; Cristea V; Berindan-Neagoe I
    Pancreas; 2009 Jul; 38(5):594-5. PubMed ID: 19550277
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.